Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q40464085)
Watch
English
Clinical Studies with Modulators of Multidrug Resistance
scientific article published on April 1, 1995
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
7642468
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7642468%20AND%20SRC:MED&resulttype=core&format=json
retrieved
22 October 2019
review article
1 reference
stated in
Europe PubMed Central
title
Clinical studies with modulators of multidrug resistance
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
7642468
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7642468%20AND%20SRC:MED&resulttype=core&format=json
retrieved
22 October 2019
Clinical Studies with Modulators of Multidrug Resistance
(English)
1 reference
stated in
Crossref
DOI
10.1016/S0889-8588(18)30099-6
reference URL
https://api.crossref.org/works/10.1016/S0889-8588(18)30099-6
retrieved
8 July 2024
main subject
multiple drug resistance
1 reference
based on heuristic
inferred from title
author
Branimir Ivan Sikic
series ordinal
2
object named as
Sikic BI
1 reference
stated in
Europe PubMed Central
PubMed publication ID
7642468
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7642468%20AND%20SRC:MED&resulttype=core&format=json
retrieved
22 October 2019
author name string
G. A. Fisher
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
7642468
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7642468
retrieved
8 July 2024
language of work or name
English
1 reference
stated in
National Center for Biotechnology Information
PubMed publication ID
7642468
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7642468
retrieved
8 July 2024
publication date
1 April 1995
1 reference
stated in
Europe PubMed Central
PubMed publication ID
7642468
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7642468%20AND%20SRC:MED&resulttype=core&format=json
retrieved
22 October 2019
full work available at URL
https://doi.org/10.1016/s0889-8588(18)30099-6
online access status
open access
1 reference
stated in
Europe PubMed Central
PubMed publication ID
7642468
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7642468
retrieved
8 July 2024
https://api.elsevier.com/content/article/PII:S0889858818300996?httpAccept=text/xml
1 reference
stated in
Crossref
DOI
10.1016/S0889-8588(18)30099-6
reference URL
https://api.crossref.org/works/10.1016/S0889-8588(18)30099-6
retrieved
8 July 2024
https://api.elsevier.com/content/article/PII:S0889858818300996?httpAccept=text/plain
1 reference
stated in
Crossref
DOI
10.1016/S0889-8588(18)30099-6
reference URL
https://api.crossref.org/works/10.1016/S0889-8588(18)30099-6
retrieved
8 July 2024
published in
Hematology / Oncology Clinics of North America
1 reference
stated in
Europe PubMed Central
PubMed publication ID
7642468
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7642468%20AND%20SRC:MED&resulttype=core&format=json
retrieved
22 October 2019
volume
9
1 reference
stated in
Europe PubMed Central
PubMed publication ID
7642468
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7642468%20AND%20SRC:MED&resulttype=core&format=json
retrieved
22 October 2019
issue
2
1 reference
stated in
Europe PubMed Central
PubMed publication ID
7642468
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7642468%20AND%20SRC:MED&resulttype=core&format=json
retrieved
22 October 2019
page(s)
363-382
1 reference
stated in
Europe PubMed Central
PubMed publication ID
7642468
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7642468%20AND%20SRC:MED&resulttype=core&format=json
retrieved
22 October 2019
cites work
Phase I trial of doxorubicin with cyclosporine as a modulator of multidrug resistance.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930099-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cyclosporin A used to reverse drug resistance increases vincristine neurotoxicity
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930099-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase I and pharmacokinetic study of D-verapamil and doxorubicin
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930099-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase II trial of doxorubicin and trifluoperazine in metastatic breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930099-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930099-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase I/pharmacokinetic study of high-dose progesterone and doxorubicin
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930099-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The efflux of anthracyclines in multidrug-resistant cell lines.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930099-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Doxorubicin in combination with verapamil in advanced colorectal cancer. A phase II trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930099-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Modulation of P-glycoprotein-mediated multidrug resistance by monoclonal antibodies, immunotoxins or antisense oligodeoxynucleotides in kidney carcinoma and normal kidney cells.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930099-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Addition of verapamil and tamoxifen to the initial chemotherapy of small cell lung cancer. A phase I/II study.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930099-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Multidrug resistance in human cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930099-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Verapamil with mitoxantrone for advanced ovarian cancer: a negative phase II trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930099-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Reversal of multidrug resistance by a new lipophilic cationic molecule, S9788. Comparison with 11 other MDR-modulating agents in a model of doxorubicin-resistant rat glioblastoma cells.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930099-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase I and pharmacokinetic trial of intraperitoneal etoposide in combination with the multidrug-resistance-modulating agent dipyridamole
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930099-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Reversion of the P-glycoprotein-mediated multidrug resistance of cancer cells by FK-506 derivatives
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930099-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
MDR1 RNA levels in human renal cell carcinomas: correlation with grade and prediction of reversal of doxorubicin resistance by quinidine in tumor explants
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930099-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The effect of verapamil on the pharmacokinetics of adriamycin.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930099-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Differential modulation of doxorubicin toxicity to multidrug and intrinsically drug resistant cell lines by anti-oestrogens and their major metabolites
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930099-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Interaction of cyclosporin A with antineoplastic agents
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930099-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
P-glycoprotein in Adult Solid Tumors: Expression and Prognostic Significance
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930099-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Charles F. Kettering Prize. P-glycoprotein and resistance to anticancer drugs
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930099-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clinical and pharmacologic study of multidrug resistance reversal with vinblastine and bepridil
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930099-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase I/II trial of cyclosporine as a chemotherapy-resistance modifier in acute leukemia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930099-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
MDR expression in normal tissues. Pharmacologic implications for the clinical use of P-glycoprotein inhibitors.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930099-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Alteration of etoposide pharmacokinetics and pharmacodynamics by cyclosporine in a phase I trial to modulate multidrug resistance
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930099-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Chemosensitizing effect of an antiestrogen, toremifene, on ovarian cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930099-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
P-glycoprotein in Adult Hematologic Malignancies
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930099-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
P-glycoprotein expression in malignant lymphoma and reversal of clinical drug resistance with chemotherapy plus high-dose verapamil
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930099-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Intermittent high-dose tamoxifen as a potential modifier of multidrug resistance.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930099-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A randomised clinical study of verapamil in addition to combination chemotherapy in small cell lung cancer. West of Scotland Lung Cancer Research Group, and the Aberdeen Oncology Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930099-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Randomized phase II study of single-agent epirubicin +/- verapamil in patients with advanced metastatic breast cancer. An AIO clinical trial. Arbeitsgemeinschaft Internistische Onkologie of the German Cancer Society.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930099-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effects of verapamil on the pharmacokinetics and metabolism of epirubicin
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930099-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A phase II trial of vinblastine plus dipyridamole in advanced renal cell carcinoma. A Hoosier Oncology Group Study.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930099-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Multidrug resistance (mdr) genes in human cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930099-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Intravesical instillation of adriamycin in the presence or absence of verapamil for the treatment of superficial bladder cancer: preliminary report of a collaborative study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930099-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Verapamil and adriamycin in the treatment of drug-resistant ovarian cancer patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930099-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Reversal of Drug Resistance in a Human Colon Cancer Xenograft Expressing MDR1 Complementary DNA by In Vivo Administration of MRK-16 Monoclonal Antibody
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930099-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A phase I study on the reversal of multidrug resistance (MDR) in vivo: nifedipine plus etoposide
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930099-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Verapamil reversal of clinical doxorubicin resistance in human cancer. A Wilshire Oncology Medical Group pilot phase I-II study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930099-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Reversal of multidrug resistance in Friend leukemia cells by dexniguldipine-HCl
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930099-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase II study of combining vinblastine and cyclosporin-A to circumvent multidrug resistance in renal cell cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930099-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Modulation of vinblastine resistance with cyclosporine: a phase I study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930099-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pharmacokinetic interaction between epirubicin and the multidrug resistance reverting agent D-verapamil
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930099-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930099-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Modulation of multidrug-resistant multiple myeloma by cyclosporin. The Leukaemia Group of the EORTC and the HOVON
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930099-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
P-glycoprotein binding and modulation of the multidrug-resistant phenotype by estramustine
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930099-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
High-dose tamoxifen as an enhancer of etoposide cytotoxicity. Clinical effects and in vitro assessment in p-glycoprotein expressing cell lines
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930099-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Modulation of doxorubicin resistance in multidrug-resistant cells by liposomes
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930099-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
High-dose oral tamoxifen, a potential multidrug-resistance-reversal agent: phase I trial in combination with vinblastine
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930099-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Resistance modification by PSC-833, a novel non-immunosuppressive cyclosporin A
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930099-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Expression of p170 protein in multiple myeloma: a clinical study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930099-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Bepridil in combination with anthracyclines to reverse anthracycline resistance in cancer patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930099-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A phase II study of epidoxorubicin in colorectal cancer and the use of cyclosporin-A in an attempt to reverse multidrug resistance
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930099-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
EPOCH chemotherapy: toxicity and efficacy in relapsed and refractory non-Hodgkin's lymphoma.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930099-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Quinidine as a resistance modulator of epirubicin in advanced breast cancer: mature results of a placebo-controlled randomized trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930099-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase I trial of etoposide with cyclosporine as a modulator of multidrug resistance
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930099-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Modulation of the function of P-glycoprotein by estramustine.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930099-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Multidrug resistance in lymphomas.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930099-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clinical trial of continuous infusion verapamil, bolus vinblastine, and continuous infusion VP-16 in drug-resistant pediatric tumors
series ordinal
8
1 reference
stated in
Crossref
DOI
10.1016/S0889-8588(18)30099-6
reference URL
https://api.crossref.org/works/10.1016/S0889-8588(18)30099-6
retrieved
8 July 2024
Phase I pharmacokinetic study of cyclosporin A combined with doxorubicin
series ordinal
22
1 reference
stated in
Crossref
DOI
10.1016/S0889-8588(18)30099-6
reference URL
https://api.crossref.org/works/10.1016/S0889-8588(18)30099-6
retrieved
8 July 2024
Reversal by cefoperazone of resistance to etoposide, doxorubicin, and vinblastine in multidrug resistant human sarcoma cells
series ordinal
30
1 reference
stated in
Crossref
DOI
10.1016/S0889-8588(18)30099-6
reference URL
https://api.crossref.org/works/10.1016/S0889-8588(18)30099-6
retrieved
8 July 2024
Idarubicin is active on MDR cells: evaluation of DNA synthesis inhibition on P388 cell lines
series ordinal
63
1 reference
stated in
Crossref
DOI
10.1016/S0889-8588(18)30099-6
reference URL
https://api.crossref.org/works/10.1016/S0889-8588(18)30099-6
retrieved
8 July 2024
Identifiers
DOI
10.1016/S0889-8588(18)30099-6
1 reference
stated in
Europe PubMed Central
PubMed publication ID
7642468
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7642468%20AND%20SRC:MED&resulttype=core&format=json
retrieved
22 October 2019
PubMed publication ID
7642468
1 reference
stated in
Europe PubMed Central
PubMed publication ID
7642468
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7642468%20AND%20SRC:MED&resulttype=core&format=json
retrieved
22 October 2019
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
